Dr. Karina Eterovic has been added to the team of Viracor Eurofins as the Director of Research & Development for Oncology Diagnostics.
FREMONT, CA: Viracor Eurofins has appointed Karina Eterovic, Ph.D., as the Director of Research & Development for Oncology Diagnostics. Dr. Eterovic leads the development and growth of oncology clinical diagnostic solutions, benefiting Viracor Eurofins' healthcare clients and patients. Dr. Eterovic has served as an Associate Professor and Director of the Cancer Genomics Laboratory from MD Anderson Cancer Center. She was the driving force in the deployment of precision medicine at the prestigious institute, establishing a genomics laboratory for their next-generation sequencing research projects. Dr. Eterovic has enabled the identification and discovery of new biomarkers for customized cancer care.
Dr. Eterovic has authored several publications in high impact oncology journals and holds both her Ph.D. in Biochemistry and Molecular Biology. She also holds a Master's degree in Biochemistry from the University of Sao Paulo, Medical School, in Brazil, and postdoctoral training in Neuro-Oncology at MD Anderson. Viracor Eurofins is thrilled to have Dr. Eterovic on their team as she will bring a wealth of knowledge from her comprehensive experience in academia, assay development, and operational management in both the U.S. and worldwide. Dr. Eterovic's keen insight enables her to identify essential unmet needs and underserved markets that will help the company expand. Viracor Eurofins is excited to expand on its infectious disease, allergy, and immunology portfolios, by providing cutting-edge test solutions in drug development and cancer diagnostics.
Viracor Eurofins is a global pioneer in laboratory services for specialty clinical diagnostics, discovery pharmacology, and supporting clinical studies. The company serves many leading biopharmaceutical companies and a wide range of clinical and academic customers in the U.S. Viracor Eurofins has more than 30 years of specialized expertise in infectious disease, allergy testing, and immunology for immunocompromised and critical patients. Viracor aims to help medical professionals, transplant teams, reference laboratories, and biopharmaceutical companies get results faster when it matters most.
